Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/apr7-qc08

technical paper

ENDO 2022

July 11, 2022

Atlanta, United States

Characterizing the Impact of Burosumab on Bone Health in Children with X-Linked Hypophosphatemia: Results from Year 1 of the Disease Monitoring Program

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2022

Hypophosphatemia Gene Panel Sponsored Program: A High Yield of Molecular Diagnoses from Clinically Confirmed XLH and Suspected Genetic Hypophosphatemia
technical paper

Hypophosphatemia Gene Panel Sponsored Program: A High Yield of Molecular Diagnoses from Clinically Confirmed XLH and Suspected Genetic Hypophosphatemia

ENDO 2022

Kathryn Dahir

11 July 2022

Similar lecture

The Role Of Nuclear Receptor Coregulator Grip1 In Homeostatic Programming Of Macrophages
technical paper

The Role Of Nuclear Receptor Coregulator Grip1 In Homeostatic Programming Of Macrophages

ENDO 2022

Marija Dacic

11 July 2022

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved